Background and AimsSanqi ginseng (Panax notoginseng) growth is often hampered by replant failure. In this study, we aimed to examine the role of autotoxicity in Sanqi replant failures and assess the role of ginsenosides in autotoxicity.MethodsThe autotoxicities were measured using seedling emergence bioassays and root cell vigor staining. The ginsenosides in the roots, soils, and root exudates were identified with HPLC-MS.ResultsThe seedling emergence and survival rate decreased significantly with the continuous number of planting years from one to three years. The root exudates, root extracts, and extracts from consecutively cultivated soils also showed significant autotoxicity against seedling emergence and growth. Ginsenosides, including R1, Rg1, Re, Rb1, Rb3, Rg2, and Rd, were identified in the roots and consecutively cultivated soil. The ginsenosides, Rg1, Re, Rg2, and Rd, were identified in the root exudates. Furthermore, the ginsenosides, R1, Rg1, Re, Rg2, and Rd, caused autotoxicity against seedling emergence and growth and root cell vigor at a concentration of 1.0 µg/mL.ConclusionOur results demonstrated that autotoxicity results in replant failure of Sanqi ginseng. While Sanqi ginseng consecutively cultivated, some ginsenosides can accumulate in rhizosphere soils through root exudates or root decomposition, which impedes seedling emergence and growth.

No abstract

SummarySwine leucocyte antigen (SLA) class II molecules on porcine (p) cells play a crucial role in xenotransplantation as activators of recipient human CD4 + T cells. A human dominant-negative mutant class II transactivator (CIITA-DN) transgene under a CAG promoter with an endotheliumspecific Tie2 enhancer was constructed. CIITA-DN transgenic pigs were produced by nuclear transfer/embryo transfer. CIITA-DN pig cells were evaluated for expression of SLA class II with/without activation, and the human CD4 + T-cell response to cells from CIITA-DN and wild-type (WT) pigs was compared. Lymphocyte subset numbers and T-cell function in CIITA-DN pigs were compared with those in WT pigs. The expression of SLA class II on antigen-presenting cells from CIITA-DN pigs was significantly reduced (40-50% reduction compared with WT; P < 0Á01), and was completely suppressed on aortic endothelial cells (AECs) even after activation (100% suppression; P < 0Á01). The human CD4 + T-cell response to CIITA-DN pAECs was significantly weaker than to WT pAECs (60-80% suppression; P < 0Á01). Although there was a significantly lower frequency of CD4 + cells in the PBMCs from CIITA-DN (20%) than from WT (30%) pigs (P < 0Á01), T-cell proliferation was similar, suggesting no significant immunological compromise. Organs and cells from CIITA-DN pigs should be partially protected from the human cellular immune response.

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause the disease cystic fibrosis. We previously reported that gentamicin administration suppressed a CFTR premature stop mutation in a Cftr-/- mouse model carrying a human CFTR-G542X (hCFTR-G542X) transgene, resulting in the appearance of hCFTR protein and function. However, the high doses used in that study resulted in peak serum levels well beyond the levels typically administered to humans. To address this problem, we identified doses of both gentamicin and amikacin that resulted in peak serum levels within their accepted clinical ranges. We then asked whether these doses could suppress the hCFTR-G542X mutation in the Cftr-/- hCFTR-G542X mouse model. Our results indicate that low doses of each compound restored some hCFTR protein expression and function, as shown by immunofluorescence and short-circuit current measurements. However, we found that amikacin suppressed the hCFTR-G542X premature stop mutation more effectively than gentamicin when administered at these clinically relevant doses. Because amikacin is also less toxic than gentamicin, it may represent a superior choice for suppression therapy in patients that carry a premature stop mutation in the CFTR gene.

Two-dimensional (2D) materials are of considerable interest for catalyzing the heterogeneous conversion of CO 2 to synthetic fuels. In this regard, 2D siloxene nanosheets, have escaped thorough exploration, despite being composed of earth-abundant elements. Herein we demonstrate the remarkable catalytic activity, selectivity, and stability of a nickel@siloxene nanocomposite; it is found that this promising catalytic performance is highly sensitive to the location of the nickel component, being on either the interior or the exterior of adjacent siloxene nanosheets. Control over the location of nickel is achieved by employing the terminal groups of siloxene and varying the solvent used during its nucleation and growth, which ultimately determines the distinct reaction intermediates and pathways for the catalytic CO 2 methanation. Significantly, a CO 2 methanation rate of 100 mmol g Ni −1 h −1 is achieved with over 90% selectivity when nickel resides specifically between the sheets of siloxene.

Diabetes is associated with an increase in circulating advanced glycosylation end products (AGEs) and the increased expression of the receptor for AGEs (RAGE). Inhibition of AGE/RAGE binding through the administration of soluble RAGE (sRAGE) has been shown to decrease neointimal hyperplasia. Peroxisome proliferator-activated receptor ␥ (PPAR␥), which inhibits neointimal hyperplasia, has been shown to decrease RAGE expression in cultured endothelial cells. We hypothesized that PPAR␥ agonists inhibit neointimal hyperplasia via down-regulation of RAGE in vivo. Pretreatment of rat aortic smooth muscle cells (SMCs) with PPAR␥ agonist rosiglitazone significantly down-regulated RAGE expression and inhibited SMC proliferation in response to the RAGE agonist S100/calgranulins. In vivo studies showed that rosiglitazone decreased RAGE expression and SMC proliferation at 7 days following carotid arterial injury in both diabetic and nondiabetic rats. At 21 days following injury, neointimal formation was significantly decreased in both diabetic and nondiabetic animals that received rosiglitazone. To determine whether inhibition of neointimal formation by PPAR␥ activation could fully be accounted for by its down-regulation of RAGE, we compared the results obtained in animals treated with sRAGE, PPAR␥ activator, and sRAGE ϩ PPAR␥ activator. Consistent with PPAR␥ working through its effects on RAGE, we found that the addition of PPAR␥ activator to sRAGE did not result in any further decrease in neointimal formation. These data demonstrate for the first time that PPAR␥ agonists inhibit RAGE expression at sites of arterial injury and suggest that down-regulation of RAGE by the PPAR␥ activation inhibits neointimal formation in response to arterial injury.Studies on arterial injury in animal models and human patients have demonstrated a clear link between inflammation and neointimal hyperplasia that is exacerbated in the setting of diabetes (Faries et al

In terms of ligand-directed synthetic strategy, multifunctional metal−organic frameworks (MOFs) could be assembled by employing organic ligands with nitrogen-containing heterocycles, which could serve as Lewis base sites in crystallized porous frameworks. Here, the acidic one-pot hydrothermal reaction of CaCl 2 , Zn(NO 3 ) 2 , and 2,4,6-tri(2,4-dicarboxyphenyl)pyridine (H 6 TDP) generates one robust honeycomb-shaped double-walled), which has the excellent physicochemical characteristics of nanoscopic channels, high porosity (58.3%), large specific surface area, and high heat/water-resisting property. To the best of our knowledge, this is the first 3s−3d dinuclear [CaZn(CO 2 ) 6 (OH 2 )]based nanoporous host framework, whose activated state possesses the coexistence of Lewis acid−base sites including four-coordinated Zn 2+ ions, four-coordinated Ca 2+ ions, uncoordinated carboxyl oxygen atoms, and N pyridine atoms. As expected, because of the coexistence of Lewis acid−base nature, desolvated NUC-21 displays satisfactory catalytic activity on the chemical cycloaddition of various epoxides with CO 2 into the corresponding alkyl carbonates under comparatively mild conditions. Furthermore, the efficient conversion of benzaldehydes and malononitrile confirms that NUC-21 is simultaneously a bifunctional heterogeneous catalyst for Knoevenagel condensation reactions. Hence, the achievements broaden the way for assembling nanoporous multifunctional MOFs by employing ligand-directed synthetic strategy, which can accelerate the transformation from simple structural research to socially demanding applications.

Epithelial-mesenchymal transition (EMT) plays a critical role in embryonic development, wound healing, tissue regeneration, cancer progression and organ fibrosis. The proximal tubular epithelial cells undergo EMT, resulting in matrix-producing fibroblasts and thereby contribute to the pathogenesis of renal fibrosis. The profibrotic cytokine, TGF-β, is now recognized as the main pathogenic driver that has been shown to induce EMT in tubular epithelial cells. Increasing evidence indicate that HIPK2 dysfunction may play a role in fibroblasts behavior, and therefore, HIPK2 may be considered as a novel potential target for anti-fibrosis therapy. Recently, members of the miR-200 family (miR-200a, b and c and miR-141) have been shown to inhibit EMT. However, the steps of the multifactorial renal fibrosis progression that these miRNAs regulate, particularly miR-141, are unclear. To study the functional importance of miR-141 in EMT, a well-established in vitro EMT assay was used to demonstrate renal tubulointerstitial fibrosis; transforming growth factor-β1-induced EMT in HK-2 cells. Overexpression of miR-141 in HK-2 cells, either with or without TGF-β1 treatment, hindered EMT by enhancing E-cadherin and decreasing vimentin and fibroblast-specific protein 1 expression. miR-141 expression was repressed during EMT in a dose- and time-dependent manner through upregulation of HIPK2 expression. Ectopic expression of HIPK2 promoted EMT by decreasing E-cadherin. Furthermore, co-transfection of miR-141 with the HIPK2 ORF clone partially inhibited EMT by restoring E-cadherin expression. miR-141 downregulated the expression of HIPK2 via direct interaction with the 3′-untranslated region of HIPK2. Taken together, these findings aid in the understanding of the role and mechanism of miR-141 in regulating renal fibrosis via the TGF-β1/miR-141/HIPK2/EMT axis, and miR-141 may represent novel biomarkers and therapeutic targets in the treatment of renal fibrosis.